Predictors of a positive baseline bone scan in breast cancer

Australasian Radiology

Volumn 49, Issue 1, 2005, Pages 21-26

  Ho, Yvonne Y ^a   Chan, Y H ^b,c  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b Clinical Trials and Epidemiology Research Unit   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Breast neoplasms; Neoplasm metastasis; Prognosis; Technetium tc 99m medronate

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AXILLARY LYMPH NODE; BONE SCINTISCANNING; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PREDICTION; PRIORITY JOURNAL; RESOURCE MANAGEMENT; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TECHNETIUM TC 99M MEDRONATE;

EID: 15244350109     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2005.01388.x     Document Type: Article

References (17)

1. Harris JR, Lippman ME, Veronesi U, Willet W. Breast cancer. N Engl J Med 1992; 327: 473-80.
2. Mansour EG, Ravdin PM, Dressler L. Prognostic factors in early breast carcinoma. Cancer 1994; 74: 381-400.
3. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997; 79: 1918-22.
4. Curigliano G, Ferretti G, Colleoni M et al. Bone scan had no role in the staging of 765 consecutive operable T(1-2)N(0-1) breast cancer patients without skeletal symptoms. Ann Oncol 2001; 12: 724-5.
5. Ravaioli A, Tassinari D, Pasini G et al. Staging of breast cancer: What standards should be used in research and clinical practice? Ann Oncol 1998; 9: 1173-7.
6. Samant R, Ganguly P. Staging investigations in patients with breast cancer: The role of bone scans and liver imaging. Arch Surg 1999; 134: 551-3.
7. Myers RE, Johnston M, Pritchard K, Levine M, Oliver T. Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative. Baseline staging tests in primary breast cancer: A practice guideline. CMAJ 2001; 164: 1439-44.
8. Smith TJ, Davidson NE, Schapira DV et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999; 17: 1080-82.
9. Brar HS, Sisley JF, Johnson RH Jr. Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients. Am J Surg 1993; 165: 221-3.
10. Koizumi M, Yoshimoto M, Kasumi F, Ogata E. What do breast cancer patients benefit from staging bone scintigraphy? Jpn J Clin Oncol 2001; 31: 263-9.
11. Yip CH, Paramsothy M. Value of routine 99mTc-MDP bone scintigraphy in the detection of occult skeletal metastases in women with primary breast cancer. Breast 1999; 8: 267-9.
12. Singletary SE, Allred C, Ashley P et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628-36.
13. Jacobson AF, Shapiro CL, Van den Abbeele AD, Kaplan WD. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma. Cancer 2001; 91: 17-24.
14. Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992; 22: 207-19.
15. Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg 1999; 230: 692-700.
16. Olivotto IA, Jackson JSH, Mates D et al. Prediction of axillary lymph node involvement of women with invasive breast carcinoma. A multivariate analysis. Cancer 1998; 83; 948-55.
17. Mirza AN, Mirza NQ, Vlastos G, Singletary SE. Prognostic factors in node-negative breast cancer: A review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 2002; 235: 10-26.